Intern, Biostatistics

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The intern will work for 8-12 weeks on theoretical or applied problems with direct relevance to on-going clinical drug development research in Oncology.

Requirements

• Strong programming skills in SAS or R
• Solid background on survival analysis
• Demonstrated problem-solving ability and strong oral and written communication skills
• Enrollment in a full-time graduate program and have completed at least two full years of graduate course work prior to the start of the internship

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits